Clinicopathological Features of Young Versus Older Patients With Breast Cancer at a Single Pakistani Institution and a Comparison With a National US Database

Sana Zeeshan, Basim Ali, Khabir Ahmad, Anees B Chagpar, Abida K Sattar, Sana Zeeshan, Basim Ali, Khabir Ahmad, Anees B Chagpar, Abida K Sattar

Abstract

Purpose: The age at which women present with breast cancer varies widely among nations, and breast cancer may behave differently in younger women. Differences in clinicopathological characteristics based on age have not been well characterized in Pakistani patients with breast cancer.

Methods: We conducted a retrospective review of patients with symptoms of breast cancer presenting to Aga Khan University Hospital (AKUH), a large tertiary care center in Pakistan, between 2001 and 2010; we compared young (≤ 40 years) versus older (> 40 years) patients in terms of their clinicopathological characteristics. We also compared this Pakistani cohort with the US population using data from the National Cancer Database (NCDB).

Results: A total of 1,334 patients with breast cancer presented to our center over the 10-year review period. The median age at diagnosis was 50 years, compared with 60 years for patients in the NCDB. In the AKUH cohort, younger patients were significantly more likely than their older counterparts to present with metastatic disease (13.1% v 10.8%; P < .01). They also were more likely to present with higher-grade tumors (grade 3: 40.1% v 28.3%; P < .001), have triple hormone receptor-negative phenotype (25.4% v 14.1%, P < .001), and have positive axillary lymph node involvement (70.9% v 57.5%; P < .001) compared with older women. Younger and older patients in the AKUH cohort tended to present with higher-stage disease ( P < .001) and were more likely to have triple hormone receptor-negative disease ( P < .001), compared with all patients in the NCDB and with those of Indo-Pakistani origin.

Conclusion: Young Pakistani women, similar to their Western counterparts, present with more advanced disease and more aggressive tumor biology than their older counterparts.

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jgo/site/misc/authors.html.

No potential conflicts of interest were reported.

Figures

FIG 1
FIG 1
Age distribution of Pakistani versus US population. Teal bars show distribution from Aga Khan University (AKU); red bars show distribution from National Cancer Database (NCDB).

References

    1. Paluch-Shimon S, Pagani O, Partridge AH, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3) Breast. 2017;35:203–217.
    1. Anders CK, Johnson R, Litton J, et al. Breast cancer before age 40 years. Sem Oncol. 2009;36(3):237–249.
    1. Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100:1643–1648.
    1. Assi HA, Khoury KE, Dbouk H, et al. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis. 2013;5:S2–8. (suppl 1)
    1. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA. Emerging breast cancer epidemic: Evidence from Africa. Breast Cancer Res. 2010;12:S8. (suppl 4)
    1. Jazayeri SB, Saadat S, Ramezani R, et al. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol. 2015;39:519–527.
    1. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: A literature and registry analysis. Int J Surg. 2007;5:225–233.
    1. Fredholm H, Magnusson K, Lindstrom LS, et al. Long-term outcome in young women with breast cancer: A population-based study. Breast Cancer Res Treat. 2016;160:131–143.
    1. Brandt J, Garne Tengrup I, et al. Age at diagnosis in relation to survival following breast cancer: A cohort study. World J Surg Oncol. 2015;13:33.
    1. Chen HL, Zhou MQ, Tian W, et al. Effect of age on breast cancer patient prognoses: A population-based study using the SEER 18 database. PloS One. 2016;11:e0165409.
    1. Khaliq SA, Naqvi SB, Fatima A. Retrospective study of cancer types in different ethnic groups and genders at Karachi. Springerplus. 2013;2:118.
    1. Sarwar MR, Saqib A. Cancer prevalence, incidence and mortality rates in Pakistan in 2012. Cogent Med. 2017;4:1288773.
    1. Lateef F, Jamal S, Nasir S, et al. Invasive ductal carcinoma: correlation of immunophenotypic features with age. J Coll Physicians Surg Pak. 2017;27:18–22.
    1. Badar F, Mahmood S, Faraz R, et al. Epidemiology of breast cancer at the Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan. J Coll Physicians Surg Pak . 2015;25(10):738–742.
    1. Azim HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16:427.
    1. Kroman N, Jensen MB, Wohlfahrt J, et al. Factors influencing the effect of age on prognosis in breast cancer: Population based study. BMJ . 2000;320:474–478.
    1. Gajdos C, Tartter PI, Bleiweiss IJ, et al. Stage 0 to stage III breast cancer in young women. J Am Coll Surg. 2000;190:523–529.
    1. Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes?. J Clin Oncol. 2011;29:e18–e20.

Source: PubMed

3
Předplatit